Inhibition of interleukin 6 signalling and renal function: A Mendelian randomization study

Inhibition of interleukin 6 (IL‐6) signalling has been proposed as a potential cardioprotective strategy for patients with chronic kidney disease (CKD), but the direct effects of IL‐6 inhibition on renal function are not known. A Mendelian randomization (MR) study was performed to investigate the as...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, David K., Karhunen, Ville, Walker, Drew J., Gill, Dipender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327328/
https://www.ncbi.nlm.nih.gov/pubmed/33393675
http://dx.doi.org/10.1111/bcp.14725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327328/
https://www.ncbi.nlm.nih.gov/pubmed/33393675
http://dx.doi.org/10.1111/bcp.14725

Ejemplares similares